Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03970655 · ClinicalTrials.gov registry record · Phase 1
Functional Endoscopic Sinus Surgery Study
A Phase 1 study of Chronic Rhinosinusitis (Diagnosis), sponsored by University of Florida.
- Active
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT03970655: Active Phase 1 study of Chronic Rhinosinusitis (Diagnosis), sponsored by University of Florida.
NCT03970655 is a Phase 1 study of Chronic Rhinosinusitis (Diagnosis) that is active but no longer recruiting, run by University of Florida. The registered enrollment target is 80 participants, roughly in line with the 82-participant average among 9 other Chronic Rhinosinusitis (Diagnosis) trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03970655, a Phase 1 study of Chronic Rhinosinusitis (Diagnosis), is active but no longer recruiting, sponsored by University of Florida.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to evaluate the effect of the addition of epinephrine to bilateral real time ultrasound guided pterygopalatine ganglion blocks on intra-operative bleeding and blood loss during functional endoscopic sinus surgery (FESS).
Primary Outcome
Endoscopic Grading of Nasal Bleeding will be calculated using the 0-5 point Boezaart surgical field grading scale; 0 being no bleeding and 5 being severe bleeding.
Conditions Studied
Interventions
- DRUG Bupivacaine or Ropivacaine with epinephrine plus dexamethasone - Group 1
- DRUG Bupivacaine or Ropivacaine with epinephrine plus dexamethasone - Group 2
Study Locations (1)
Florida
- UF Health of University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2019-09-25 |
| Est. Completion | 2027-01-23 |
| Phase | Phase 1 |
What the registry record for NCT03970655 still lists
NCT03970655 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, roughly in line with the 82-participant average among 9 other Chronic Rhinosinusitis (Diagnosis) trials with a reported enrollment target.
The record links to 1 condition, with Chronic Rhinosinusitis (Diagnosis) appearing as the primary indexed condition, and to 2 interventions - of which Bupivacaine or Ropivacaine with epinephrine plus dexamethasone - Group 1 is the first listed.
NCT03970655 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03970655 about?
NCT03970655 is a clinical study titled "Functional Endoscopic Sinus Surgery Study". The aim of this study is to evaluate the effect of the addition of epinephrine to bilateral real time ultrasound guided pterygopalatine ganglion blocks on intra-operative bleeding and blood loss during functional endoscopic sinus surgery (FESS).
What is the current status of trial NCT03970655?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2019-09-25. Estimated completion is 2027-01-23.
What conditions does trial NCT03970655 study?
This clinical trial studies the following conditions: Chronic Rhinosinusitis (Diagnosis).
What interventions are being tested in trial NCT03970655?
The interventions under investigation include: Bupivacaine or Ropivacaine with epinephrine plus dexamethasone - Group 1 (DRUG), Bupivacaine or Ropivacaine with epinephrine plus dexamethasone - Group 2 (DRUG).
Who is sponsoring clinical trial NCT03970655?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03970655 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Rhinosinusitis (Diagnosis)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03970655's enrollment target sits among peer trials
80 3rd of 9 higher than 6 of 9 other Chronic Rhinosinusitis (Diagnosis) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Rhinosinusitis (Diagnosis) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis
RECRUITING · Early Phase 1
-
The Role of IL5 in Epithelial Cell Integrity
RECRUITING · Early Phase 1
-
Sinus Disease in Young Children With Cystic Fibrosis
RECRUITING
-
Topical Probiotic Sinus Irrigations for Treating Chronic Sinusitis
RECRUITING · Phase 2
-
Impact of Sinus Surgery on Individuals With Cystic Fibrosis
RECRUITING
-
The Sinonasal Microbiome
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI